serine/threonine Kinase 17a (STK17A) (N-Term) Peptide

Details for Product No. ABIN1382030
Request Want additional data for this product?

The Independent Validation Initiative strives to provide you with high quality data. Find out more

 
Protein Name
Synonyms DRAK1, RDRAK1, im:6905684, LOC100226911, STK17A
Protein Region
N-Term
Origin
Human
(1)
Application
Blocking Peptide (BP)
Pubmed 3 references available
Catalog no. ABIN1382030
Quantity 0.05 mg
Price
77.00 $   Plus shipping costs $45.00
Shipping to United States (Change)
Availability Will be delivered in 2 to 3 Business Days

Order hotline:

  • +1 404 474 4654
  • +1 888 205 9894 (TF)
Characteristics 15 amino amino terminus of human DRAK1.
Human
Alternative Name DRAK1
Research Area Signaling, Apoptosis/Necrosis
Application Notes DRAK1 peptide is used for blocking the activity of DRAK1.
Restrictions For Research Use only
Format Liquid
Concentration 200 µg/mL
Buffer PBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1 % bovine serum albumin and 0.02 % sodium azide
Preservative Sodium azide
Storage -20 °C
Expiry Date 12 months
Background publications Wesche, Korherr, Kracht et al.: "The interleukin-1 receptor accessory protein (IL-1RAcP) is essential for IL-1-induced activation of interleukin-1 receptor-associated kinase (IRAK) and stress-activated protein kinases (SAP kinases)." in: The Journal of biological chemistry, Vol. 272, Issue 12, pp. 7727-31, 1997 (PubMed).

Hofmeister, Wiegmann, Korherr et al.: "Activation of acid sphingomyelinase by interleukin-1 (IL-1) requires the IL-1 receptor accessory protein." in: The Journal of biological chemistry, Vol. 272, Issue 44, pp. 27730-6, 1997 (PubMed).

Sanjo, Kawai, Akira: "DRAKs, novel serine/threonine kinases related to death-associated protein kinase that trigger apoptosis." in: The Journal of biological chemistry, Vol. 273, Issue 44, pp. 29066-71, 1998 (PubMed).

Reactivities (1)
back to top